Synopsis L-Ascorbic Acid 6-Palmitate is a lipid soluble ester of ascorbic acid. The global L-Ascorbic Acid 6-Palmitate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 20.....
SynopsisBenzyl azide is an aromatic azide generally used in copper(I)-catalyzed azide-alkyne cycloaddition reactions. The global Benzyl Azide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during .....
SynopsisFerric stearate(CAS 555-36-2) is an orange-red compound that is non-toxic, odorless, tasteless and non-flammable. The global Ferric Stearate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % .....
Synopsis1-Acetyl-2-Phenylhydrazine(CAS 114-83-0) which reacts with oxyhaemoglobin to form free radicals may be used to induce haemolytic anaemia for studies of the hematopoietic system. The global 1-Acetyl-2-Phenylhydrazine market was valued at US$ million in 20.....
SynopsisSemagacestat is an inhibitor of the γ-secretase complex. It causes a reduction in the secretion of Aβ42, Aβ40 and Aβ38 from H4 human glioma cells stably overexpressing human wild-type APP into the culture medium. The global Semagacestat market was valued.....
SynopsisPurvalanol A is a cell-permeable, potent, and selective inhibitor of cyclin-dependent kinases. The global Purvalanol A (CDK Inhibitor) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during.....
SynopsisIndoprofen(CAS 31842-01-0) is a non-steroidal drug, which can show a range of pharmacological properties such as analgesic and anti-inflammatory activities. The global Indoprofen market was valued at US$ million in 2023 and is anticipated to reach US$ mi.....
SynopsisPeficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. The global Peficitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,.....
SynopsisBaricitinib (CAS 1187594-09-7) is an orally bioavailable inhibitor of Janus kinases 1 and 2, with potential anti-inflammatory, immunomodulating and antineoplastic activities. The global Baricitinib market was valued at US$ million in 2023 and is anticipa.....
SynopsisValrubicin (CAS 56124-62-0) is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. The global Valrubicin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % d.....
